ERDERA
Multinational research teams are invited to apply for ERDERA’s 2026 call focused on providing diagnostic clarity for unsolved rare genetic and nongenetic diseases. The call aims to close these gaps and deliver actionable diagnostic evidence for patients and families. Read more at this LINK.
Open Calls
Deadline for pre-proposal submission - 12 February 2026
Deadline for full proposal submission - 08 July 2026
EP PerMed
The European Partnership for Personalised Medicine (EP PerMed) is a Horizon Europe-funded initiative (launched in Nov 2023) that coordinates research, innovation, and implementation across Europe to accelerate personalised medicine. It brings together national/regional funding bodies, ministries, healthcare providers, industry, researchers, and patients to support the full “value continuum” — from basic research to clinical pilots and health system uptake.
Key goals include:
- Translating scientific discoveries into patient-centred applications
- Integrating big data, digital health, and omics technologies
- Strengthening health systems’ capacity to adopt personalised approaches
- Demonstrating the value (clinical, societal, economic) of personalised medicine for sustainable healthcare
To steer its work, EP PerMed follows a Strategic Research & Innovation Agenda (SRIA) that defines priorities and supports joint calls, pilot projects, capacity building, and policy dialogue.
Open Calls
no updates
IHI
The Innovative Health Initiative (IHI) is a European Partnership under Horizon Europe, funded jointly by the European Union via HE and by health industry partners.
The Innovative Health Initiative (IHI) is a large-scale public–private partnership that brings together the EU and health industry stakeholders to accelerate the development of innovative healthcare solutions. It funds collaborative, cross-sector projects that tackle complex challenges—spanning medicines, medical technologies, digital health, and patient care. By fostering collaboration between academia, industry, SMEs, and patient organisations, IHI aims to deliver more integrated, sustainable, and patient-centred innovations for Europe’s health systems.
Open Calls:
The Innovative Health Initiative (IHI) Draft topics for upcoming Innovative Health Initiative (IHI) calls are now available, with updates expected in early June. If you are planning to apply, registration for the IHI Call Days is now open — a key opportunity to learn more about the calls, funding priorities and application process. IHI is also offering training and masterclasses on its “Field Manual for Scaling Innovation” to help projects turn research results into real-world impact.
The IHI Call Days for IHI call 13 will take place from 24 to 30 June online and will include sessions on the individual topics as well as the rules and procedures. It will spotlight some of the most pressing challenges and opportunities in health innovation, from advancing immuno-science in age-related diseases to exploring the future of AI-driven toxicology models for safer drug development.
Sessions will also cover the launch of the European healthcare incubator network and provide practical guidance on the rules and procedures for two-stage calls, helping applicants navigate upcoming funding opportunities and collaborative research initiatives – Register here
Mission Cancer
Horizon Europe Missions are a new programming approach under Pillar II – Global Challenges and European Industrial Competitiveness, designed with a horizontal, inter-cluster structure. They tackle major social and environmental challenges through bold, measurable objectives to be achieved within clear timelines. By mobilizing researchers, businesses, policymakers, and citizens, the Missions aim to accelerate innovation and deliver tangible benefits in areas such as climate adaptation, cancer, oceans, soil health, and climate-neutral cities.
Mission Cancer
The goal of the Mission on Cancer is to improve the lives of more than 3 million people by 2030, through prevention, cure and for those affected by cancer including their families, to live longer and better.
The four Cancer Mission objectives are:
✔ Understand;
✔ Prevent what is preventable;
✔ Optimise diagnosis and treatment;
✔ Support quality of life.
Its five transversal priorities are: ensure equitable access in all aforementioned areas, innovation, childhood cancer, personalised medicine and citizen engagement.
Open Calls